PERSISTENCE OF DE NOVO DONORSPECIFIC HLA-ANTIBODIES SEEMS TO INCREASE THE RISK OF LUNG ALLOGRAFT DYSFUNCTION

被引：0
|
作者：
Schmitzer, Magdalena [1 ]
Winter, Hauke [1 ]
Kneidinger, Nikolaus [1 ]
Dick, Andrea [1 ]
Neurohr, Claus [1 ]
Kauke, Teresa [1 ]
机构：
[1] Univ Clin, Munich, Germany
来源：
HLA | 2016年 / 87卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P28
引用
收藏
页码：246 / 246
页数：1
相关论文
共 50 条
  • [1] PERSISTENCE OF DE NOVO DONOR SPECIFIC HLA-ANTIBODIES INCREASES THE RISK OF LUNG ALLOGRAFT DYSFUNCTION
    Schmitzer, M.
    Kneidinger, N.
    Dick, A.
    Neurohr, C.
    von Dossow, V.
    Schramm, R.
    Winter, H.
    Kauke, T.
    TRANSPLANT INTERNATIONAL, 2016, 29 : 14 - 15
  • [2] Persistence of de novo donor-specific HLA-antibodies after lung transplantation: A potential marker of decreased patient survival
    Schmitzer, M.
    Winter, H.
    Kneidinger, N.
    Meimarakis, G.
    Dick, A.
    Schramm, R.
    Klotz, L. V.
    Preissler, G.
    Strobl, N.
    von Dossow, V.
    Schneider, C.
    Weig, T.
    Hatz, R.
    Kauke, T.
    HLA, 2018, 92 (01) : 24 - 32
  • [3] DE NOVO THIRD PARTY HLA ANTIBODIES SYNERGIZE WITH DE NOVO DONOR SPECIFIC HLA ANTIBODIES TO NEGATIVELY IMPACT LUNG ALLOGRAFT OUTCOME
    Zhang, Aiwen
    Good, Derek J.
    Thomas, Dawn M.
    Walendzik, Allison
    Cagahastian, Van
    Allen, Jeffrey
    McMichael, John
    McCurry, Kenneth
    Budev, Marie
    Gebel, Howard M.
    Bray, Robert A.
    HUMAN IMMUNOLOGY, 2019, 80 : 32 - 33
  • [4] PERSISTENCE OF DE NOVO DSA IS ASSOCIATED WITH CHRONIC LUNG ALLOGRAFT DYSFUNCTION AFTER LUNG TRANSPLANTATION
    Schmitzer, M.
    Degenfelder, P.
    Kneidinger, N.
    Schneider, C.
    Michel, S.
    Speck, E.
    Behr, J.
    Hatz, R.
    Kauke, T.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 17 - 17
  • [5] De Novo DonorSpecific Antibodies as a Risk Marker for Early Antibody Mediated Rejection
    Letchford, D. B.
    Offen, S. M.
    Watson, N.
    Jain, P.
    Jabbour, A.
    Keogh, A.
    Kotlyar, E.
    Hayward, C. S.
    Muthiah, K.
    MacDonald, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04) : S325 - S326
  • [6] Association Between De Novo Donor Specific Antibodies and Baseline Lung Allograft Dysfunction
    Alnababteh, M.
    Keller, M. B.
    Kong, H.
    Ponor, L.
    Shah, P. M.
    Charya, A. V.
    Andargie, T.
    Mathew, J.
    Park, W.
    Aryal, S.
    Luikart, H.
    Nathan, S. D.
    Orens, J. B.
    Jang, M.
    Agbor-Enoh, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [7] HLA-CLASS II EPLET MISMATCHES BETWEEN DONOR AND LUNG RECIPIENTS AND DEVELOPMENT OF DE NOVO DONOR SPECIFIC HLA-ANTIBODIES
    Kleid, Lisa
    Tomasi, Stephanie
    Wurm, Franziska
    Zahn, Robert
    Kauke, Teresa
    Dick, Andrea
    HLA, 2021, 98 : 5 - 6
  • [8] PERSISTENCE OF DE NOVO DSA IS ASSOCIATED WITH CHRONIC LUNG ALLOGRAFT DYSFUNCTION AND REDUCED SURVIVAL AFTER LUNG TRANSPLANTATION
    Schmitzer, Magdalena
    Dick, Andrea
    Schneider, Christian
    Speck, Eike
    Michel, Sebastian
    Kauke, Teresa
    HLA, 2019, 93 (05) : 293 - 293
  • [9] DE NOVO PERSISTENT POST-TRANSPLANT HLA DONOR-SPECIFIC ANTIBODIES ARE ASSOCIATED WITH WORSE SURVIVAL AND AN INCREASED RISK OF CHRONIC LUNG ALLOGRAFT DYSFUNCTION
    Picard, Christophe
    Basire, Agnes
    Loundou, Anderson
    Pelardy, Matthieu
    Frassati, Coralie
    Bouchet, Caroline
    Thomas, Pascal Alexandre
    Reynaud-Gaubert, Martine
    TISSUE ANTIGENS, 2015, 85 (05): : 306 - 306
  • [10] Are De Novo DQ Donor-Specific Antibodies the Key to Chronic Lung Allograft Dysfunction?
    Shenoy, Kartik V.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 194 (05) : 534 - 535
12345